Atorvastatin - Medlab
Latest Information Update: 11 Aug 2016
At a glance
- Originator Medlab
- Class Amides; Antihyperlipidaemics; Fatty acids; Fluorobenzenes; Heptanoic acids; Pyrroles; Small molecules
- Mechanism of Action HMG-CoA reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypercholesterolaemia
Most Recent Events
- 01 Jan 2015 Preclinical trials in Hypercholesterolaemia in Australia (Buccal) (ACTRN12615001285549)